ERT, a global solutions provider for patient safety and efficacy endpoint data collection headquartered in Philadelphia, Pa., has completed the acquisition of Boston, Mass.-based PHT, an eClinical innovator focused on the adoption of patient-driven mobile apps for improved clinical research. Financial terms of the transaction have not been disclosed.

The acquisition further boosts ERT’s eClinical Outcome Assessments (eCOA) and patient-centric data collection, its innovative clinical trial and healthcare technologies, consulting and service offerings, with PHT’s eCOA system, eCOA scientists and customer service. The combined company will have an increased global footprint throughout North America, Europe and Asia, supporting all phases of clinical research across a broad range of therapeutic areas for small and mid-sized biopharma, CROs and large pharma.